Cargando…
Crosstalk between repair pathways elicits double-strand breaks in alkylated DNA and implications for the action of temozolomide
Temozolomide (TMZ), a DNA methylating agent, is the primary chemotherapeutic drug used in glioblastoma treatment. TMZ induces mostly N-alkylation adducts (N7-methylguanine and N3-methyladenine) and some O(6)-methylguanine (O(6)mG) adducts. Current models propose that during DNA replication, thymine...
Autores principales: | Fuchs, Robert P, Isogawa, Asako, Paulo, Joao A, Onizuka, Kazumitsu, Takahashi, Tatsuro, Amunugama, Ravindra, Duxin, Julien P, Fujii, Shingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289412/ https://www.ncbi.nlm.nih.gov/pubmed/34236314 http://dx.doi.org/10.7554/eLife.69544 |
Ejemplares similares
-
The Shu complex prevents mutagenesis and cytotoxicity of single-strand specific alkylation lesions
por: Bonilla, Braulio, et al.
Publicado: (2021) -
CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks
por: Cofsky, Joshua C, et al.
Publicado: (2020) -
Structural basis for an unprecedented enzymatic alkylation in cylindrocyclophane biosynthesis
por: Braffman, Nathaniel R, et al.
Publicado: (2022) -
Alkylative damage of mRNA leads to ribosome stalling and rescue by trans translation in bacteria
por: Thomas, Erica N, et al.
Publicado: (2020) -
Non-enzymatic primer extension with strand displacement
por: Zhou, Lijun, et al.
Publicado: (2019)